Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Staphylococcus aureus bloodstream infections: diverging trends of meticillin-resistant and meticillin-susceptible isolates, EU/EEA, 2005 to 2018 (CROSBI ID 305497)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Gagliotti, Carlo ; Högberg, Liselotte Diaz ; Billström, Hanna ; Eckmanns, Tim ; Giske, Christian G ; Heuer, Ole E ; Jarlier, Vincent ; Kahlmeter, Gunnar ; Lo Fo Wong, Danilo ; Monen, Jos et al. Staphylococcus aureus bloodstream infections: diverging trends of meticillin-resistant and meticillin-susceptible isolates, EU/EEA, 2005 to 2018 // Eurosurveillance, 26 (2021), 46; 1-9. doi: 10.2807/1560-7917.es.2021.26.46.2002094

Podaci o odgovornosti

Gagliotti, Carlo ; Högberg, Liselotte Diaz ; Billström, Hanna ; Eckmanns, Tim ; Giske, Christian G ; Heuer, Ole E ; Jarlier, Vincent ; Kahlmeter, Gunnar ; Lo Fo Wong, Danilo ; Monen, Jos ; Murchan, Stephen ; Simonsen, Gunnar Skov ; Šubelj, Maja ; Tambić Andrašević, Arjana ; Żabicka, Dorota ; Žemličková, Helena ; Monnet, Dominique L ; EARS- Net study group participants

engleski

Staphylococcus aureus bloodstream infections: diverging trends of meticillin-resistant and meticillin-susceptible isolates, EU/EEA, 2005 to 2018

Background: Invasive infections caused by Staphylococcus aureus have high clinical and epide-miological relevance. It is therefore important to moni-tor the S. aureus trends using suitable methods. Aim: The study aimed to describe the trends of blood-stream infections (BSI) caused by meticillin-resistant S. aureus (MRSA) and meticillin-susceptible S. aureus (MSSA) in the European Union (EU) and the European Economic Area (EEA). Methods: Annual data on S. aureus BSI from 2005 to 2018 were obtained from the European Antimicrobial Resistance Surveillance Network (EARS-Net). Trends of BSI were assessed at the EU/EEA level by adjusting for blood culture set rate (number of blood culture sets per 1, 000 days of hospitalisation) and stratification by patient charac-teristics.Results: Considering a fixed cohort of labo-ratories consistently reporting data over the entire study period, MRSA percentages among S. aureus BSI decreased from 30.2% in 2005 to 16.3% in 2018. Concurrently, the total number of BSI caused by S. aureus increased by 57%, MSSA BSI increased by 84% and MRSA BSI decreased by 31%. All these trends were statistically significant (p < 0.001). Conclusions: The results indicate an increasing health burden of MSSA BSI in the EU/EEA despite a significant decrease in the MRSA percentage. These findings highlight the importance of monitoring antimicrobial resistance trends by assessing not only resistance percentages but also the incidence of infections. Further research is needed on the factors associated with the observed trends and on their attributable risk.

Europe ; MRSA ; Staphylococcus aureus ; antimicrobial resistance ; bacterial infections ; bloodstream infection

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

26 (46)

2021.

1-9

objavljeno

1025-496X

1560-7917

10.2807/1560-7917.es.2021.26.46.2002094

Povezanost rada

Temeljne medicinske znanosti

Poveznice
Indeksiranost